Menu
Back to User profile » Professor Yi-Wu Dang
Papers published by Professor Yi-Wu Dang:
MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays
Gao L, Xiong D, He R, Yang X, Lai Z, Liu L, Huang Z, Wu H, Yang L, Ma J, Li S, Lin P, Yang H, Luo D, Dang Y, Chen G
OncoTargets and Therapy 2019, 12:9827-9848
Published Date: 18 November 2019
MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1
Chen ZM, Yu Q, Chen G, Tang RX, Luo DZ, Dang YW, Wei DM
Cancer Management and Research 2019, 11:4825-4837
Published Date: 27 May 2019
The coexistence of a Wilms’ tumor and renal cell carcinoma in children: a case report and review of the literature
Zou XP, Jiang YY, Liao Y, Dang YW, Chen G, Feng ZB, Ma Y
OncoTargets and Therapy 2019, 12:953-958
Published Date: 30 January 2019
Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases
Xie ZC, Dang YW, Wei DM, Chen P, Tang RX, Huang Q, Liu JH, Luo DZ
OncoTargets and Therapy 2017, 10:3991-4005
Published Date: 10 August 2017
Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study
Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G, Dang YW
OncoTargets and Therapy 2016, 9:5163-5180
Published Date: 22 August 2016
Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis
Li JJ, Liang L, Liu YR, Luo YH, Liang XN, Luo DZ, Feng ZB, Dang YW, Yang LH, Chen G
OncoTargets and Therapy 2016, 9:1721-1734
Published Date: 21 March 2016